What it sells
We deliver personalized medicine for neurodegenerative patients
Business model breakdown
Buyer: who owns the budget?
Health plans, ACOs, health systems under value-based arrangements, plus insurers paying for visits.
Trigger: what makes them buy now?
Gaps in neurology care, avoidable ED visits, CMS GUIDE dementia model.
Workflow: what inputs become what output?
Virtual intake, dedicated care team (neurologist, care coordinator, psychiatry, speech therapy, genetic counseling, insurance navigation), EHR-integrated coordination.
Economics: what it saves and how it charges
Billed to health plans (covered by most plans) and value-based partner contracts; claims reduced cost of care.
Distribution: how it reaches customers
Patient referral and intake phone/web, partner channels to payers, providers and CMS GUIDE.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2020 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.